Changes to the website
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 26 to 50 of about 4901

Previous 25           Next 25
Website Changes
10/20/2016 An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers.
10/09/2016 High response rate in phase I/II paediatric brain cancer trial
10/09/2016 Exclusive: Interview With DelMar Pharmaceutical CEO Jeffrey Bacha
10/09/2016 Darren Daulton Battling Brain Cancer Through Charitable Foundation
10/09/2016 CIK Treatment Extends Progression-free Survival of Glioblastoma Patients by 1.5 Times
10/09/2016 Last chance for NY Islanders Home Opener Fundraiser!
10/06/2016 Veteran With Terminal Brain Cancer Explains Why He’s Against Assisted Suicide
10/05/2016 Tocagen Presents Updated Tumor Response Data for its Cancer-Selective Gene Therapy
10/01/2016 Injecting live virus in brain tumors may fight cancer, study suggests
10/01/2016 Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma.
10/01/2016 Pioneering Studies Apply New Immunologic Insights to Glioblastoma
10/01/2016 Effect of Bevacizumab Plus Temozolomide-Radiotherapy for Newly Diagnosed Glioblastoma with Different MGMT Methylation Status: A Meta-Analysis of Clinical Trials.
09/30/2016 Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Glioblastoma Multiforme
09/28/2016 Glioblastoma: Overview of Disease and Treatment.
09/28/2016 Efficacy and Safety of Treating Glioblastoma With Tumor-Treating Fields Therapy
09/28/2016 The Musella Foundation For Brain Tumor Research and Information, Inc is proud to announce that we partnered with the DIPG Collaborative to award a $100,000 pediatric brain tumor research grant to Dr. Adrian Krainer, of the Cold Spring Harbor Laboratory in NY.
09/26/2016 Orbus Therapeutics Announces Enrollment of First Patient in Phase 3 Trial in Late-Stage Brain Cancer
09/21/2016 The Clinical Implications of Inconsistently Methylated Results from Glioblastoma MGMT Testing by Replicate Methylation-Specific PCR.
09/19/2016 CNS Oncology Publishes Tumor Treating Fields Treatment Planning and Patient Follow-up Guidelines in Glioblastoma
09/19/2016 Brain cancer replaces leukemia as deadliest cancer for kids, study shows
09/13/2016 The CERN Foundation recently completed the second edition of their Ependymoma Guide
09/08/2016 Monteris Medical Receives IDE Approval From FDA To Evaluate NeuroBlate® In Patients Newly Diagnosed With Glioblastoma Multiforme
09/08/2016 Human cytomegalovirus encoded chemokine receptor US28 activates the HIF-1a/PKM2 axis in glioblastoma cells.
09/07/2016 DelMar Pharmaceuticals and Accurexa to Collaborate in the Development of a Novel Combination Chemotherapy for the Local Treatment of Brain Cancer
09/07/2016 NY Islanders fundraiser for Brain Tumor Research!



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2016 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites